D-0908-2023 Class II Terminated
FDA drug recall D-0908-2023 was initiated by L. Perrigo Company on Feb 9, 2023 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Sep 11, 2023). Affected quantity: 32,376 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 19, 2023
- Initiation Date
- Feb 9, 2023
- Termination Date
- Sep 11, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 32,376 cartons
Product Description
Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 0113-0847-39), and b) 45-count cartons (NDC 0113-0847-95), Distributed by: Perrigo, Allegan, MI 49010.
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
Nationwide within the USA
Code Information
Lot #: a) 2DV1869, 2EV1613, 2EV1614, Exp. date 12/23; 2EV1820, 2FV1943, Exp. date 01/24; 2GV1893, Exp. date 04/24. Lot #: b) 2CR0653, 2DR0466, Exp. date 12/23, 2ER2087, Exp. date 01/24
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0908-2023
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026